You are here

Clinical Trials: Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, August 15, 2023 - 12:00
Condition:   Acute Ischemic Stroke
Interventions:   Drug: iEPCs;   Combination Product: Clinical standard treatment (CST)
Sponsor:   Allife Medical Science and Technology Co., Ltd.
Not yet recruiting
Posted: Tuesday, August 1, 2023 - 12:00
Condition:   Safety Issues
Intervention:   Procedure: Stromal Vascular Fraction (SVF) combined with Functional self-assembling peptide nanofiber hydrogels
Sponsor:   Kunming Tongren Hospital
Posted: Friday, July 21, 2023 - 12:00
Condition:   Acute Cerebral Ischemia
Interventions:   Drug: Sovateltide;   Other: Normal Saline
Sponsor:   Pharmazz, Inc.
Posted: Monday, July 17, 2023 - 12:00
Condition:   Charcot Marie Tooth Disease, Type 1
Intervention:   Drug: CLZ-2002
Sponsor:   Cellatoz Therapeutics, Inc
Posted: Tuesday, June 13, 2023 - 12:00
Condition:   Parkinson's Disease
Intervention:   Drug: Autologous induced neural stem cell-derived DA precursor cells
Sponsor:   Xuanwu Hospital, Beijing
Posted: Friday, June 2, 2023 - 12:00
Condition:   Refractory Focal Epilepsy
Intervention:   Drug: iPSC-Exos
Sponsors:   Peking Union Medical College Hospital;   Guidon Pharmaceutics Ltd.
Posted: Tuesday, May 9, 2023 - 12:00
Condition:   Ischemic Stroke
Intervention:   Biological: Transplantation of self BMSCs
Sponsor:   Zhujiang Hospital
Posted: Monday, May 8, 2023 - 12:00
Condition:   Myotonic Dystrophy 1
Interventions:   Dietary Supplement: Mult-ingredient supplement;   Dietary Supplement: Placebo;   Behavioral: Concurrent exercise training
Sponsor:   McMaster University
Not yet recruiting
Posted: Monday, March 13, 2023 - 12:00
Conditions:   Stroke;   Hemiparesis
Interventions:   Behavioral: Practice Variable;   Behavioral: No Practice Variable
Sponsor:   Columbia University
Posted: Monday, March 13, 2023 - 12:00
Condition:   Parkinson Disease
Interventions:   Drug: Lenrispodun;   Drug: Placebo
Sponsor:   Intra-Cellular Therapies, Inc.